Instil Bio, Inc. (TIL) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Instil Bio, Inc. (TIL) Bundle
Looking to determine the intrinsic value of Instil Bio, Inc.? Our (TIL) DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -6.5 | -33.4 | -154.0 | -217.4 | -146.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -24194.2 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .0 | .3 | 2.8 | 6.0 | 4.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 185.51 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -6.5 | -33.6 | -156.8 | -223.4 | -150.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -24379.71 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | 8.9 | 241.7 | 454.1 | 260.9 | 150.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 3.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 2299.28 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | 1.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 855.8 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.0 | 3.5 | 5.6 | 2.4 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 2532.61 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.8 | -50.8 | -57.8 | -84.6 | -20.7 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | -36823.19 | 100 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -6.5 | -33.8 | -156.8 | -221.3 | -150.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.2 | -86.2 | -205.4 | -303.1 | -167.9 | -1.2 | .0 | .0 | .0 | .0 |
| WACC, % | 10 | 10.03 | 10.03 | 10.01 | 10.03 | 10.02 | 10.02 | 10.02 | 10.02 | 10.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 77 | |||||||||
| Equity Value | -78 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | -11.99 |
What You Will Get
- Pre-Filled Financial Model: Instil Bio, Inc.'s (TIL) actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- Real-Life TIL Data: Pre-filled with Instil Bio, Inc.'s historical financials and future forecasts.
- Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Dynamic Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and suitable for both professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Instil Bio data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Instil Bio’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Instil Bio, Inc. (TIL)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Instil Bio’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use Instil Bio, Inc. (TIL)?
- Investors: Gain insights and make informed decisions with our advanced therapeutic solutions.
- Healthcare Professionals: Utilize our innovative treatments to enhance patient care and outcomes.
- Researchers: Access cutting-edge research tools to advance your studies in cell therapy.
- Pharmaceutical Companies: Collaborate with us to explore new opportunities in the biotech field.
- Educators and Students: Leverage our resources to enrich learning in biotechnology and pharmacology courses.
What the Template Contains
- Historical Data: Includes Instil Bio, Inc.'s (TIL) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Instil Bio, Inc.'s (TIL) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Instil Bio, Inc.'s (TIL) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.